| PEC0630 | Predictors of pre-exposure prophylaxis uptake among young sexual minority men and transgender women in New York City: A P18 cohort substudy | E-poster | C36 |
| PEC0631 | Measuring national disparities in pre-exposure prophylaxis (PrEP) use in US counties relative to PrEP need in 2018 | E-poster | C36 |
| PEC0632 | Awareness about and willingness to use long-acting injectable PrEP (LAIP) among people who inject drugs | E-poster | C36 |
| PEC0633 | Factors associated with interest in community pharmacy delivered pre-exposure prophylaxis amongst a cohort of patients seeking HIV testing: A retrospective cohort study | E-poster | C36 |
| PEC0634 | Barriers to uptake and use of oral PrEP among FSW in Blantyre, Malawi | E-poster | C36 |
| PEC0635 | Retention in care outcomes among key populations receiving HIV pre-exposure prophylaxis in Haiti | E-poster | C36 |
| PEC0636 | Knowledge of event-driven pre-exposure prophylaxis (ED-PrEP) among PrEP-experienced gay and bisexual men in Australia | E-poster | C36 |
| PEC0637 | Movement along the PrEP cascade in a longitudinal US national cohort of sexual minority individuals | E-poster | C36 |
| PEC0638 | Middle and high school student access to HIV prevention education and Pre-Exposure Prophylaxis (PrEP) in Oakland, California school-based and community health centers | E-poster | C36 |
| PEC0639 | Experiences of accessing HIV pre-exposure prophylaxis (PrEP) following inclusion on Australia's subsidised medicine scheme | E-poster | C36 |